The role of IL-29 in immunity and cancer
- PMID: 27637354
- PMCID: PMC7129698
- DOI: 10.1016/j.critrevonc.2016.08.002
The role of IL-29 in immunity and cancer
Abstract
Interleukin-29 (IL-29) is a new member of the recently discovered interferon λ (IFNλ) family. It is produced predominantly by maturing dendritic cells and macrophages. It has been implicated in numerous immunological responses and has shown antiviral activity similar to the Type I interferons, although its target cell population is more limited than the Type I interferons. In recent years, the role of IL-29 in the pathogenesis of various cancers has also been extensively studied. In this review, we will discuss the recent advances of IL-29 in immunological processes and the pathogenesis of various cancer.
Keywords: Cancer; Cytokine; IL-29; Immune response.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.
References
-
- Alborzi A.M., Bamdad T., Davoodian P., Hashempoor T., Nejatizadeh A.A., Moayedi J. Insights into the role of HCV plus-/minus strand RNA, IFN-γ and IL-29 in relapse outcome in patients infected by HCV. Asian Pac. J. Allergy Immunol. 2015;33 - PubMed
-
- Alexandrakis M.G., Goulidaki N., Pappa C.A., Boula A., Psarakis F., Neonakis I., Tsirakis G. Interleukin-10 induces both plasma cell proliferation and angiogenesis in multiple myeloma. Pathol. Oncol. Res. 2015;21:929–934. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources